Eli Lilly said on Wednesday patients taking its obesity drug Zepbound lost 47% more weight than those who were given Novo ...

Eli Lilly & Co. Inc.’s stock rose 1.5% early Wednesday, after the company said its Zepbound weight-loss drug was more ...

Medication fills for Zepbound have increased by more than 300% since the start of the year. The average out-of-pocket cost for patients was $230 per fill — the highest of any medication included in ...

Eli Lilly & Co. Inc.’s stock rose 1.5% early Wednesday, after the company said its Zepbound weight-loss drug was more effective than rival Novo Nordisk’s Wegovy in a head-to-head study. Zepbound ...

The randomized clinical trial showed that Zepbound patients achieved 47% more relative weight loss than Wegovy patients.

A study reveals that weight loss can lead to significant healthcare savings, with 7% savings for a 5% BMI reduction and 30% ...

The digital health industry has experienced impressive growth, driven by rising healthcare demands, digitalization, and ...

When Mineola resident Luna Cruz was 5 years old, she began experiencing concerning symptoms: extreme fatigue, frequent ...

Another tranche of €6 billion of Apple tax money was added to the Irish exchequer last month, according to the Department of ...

Swiss health insurance companies spent CHF9 billion on medicines for basic insurance, almost 6% more than in the previous year.

Thanks to effective and popular new drugs for weight loss and diabetes – an estimated 1 in 8 adults in the US has used ...